The arrival of a 750 mcg teriparatide injection in Australia has generated considerable discussion within the medical community. Currently, its availability is restricted, primarily by specialist doctors and registered centers. Distribution figures for this specific dosage remain somewhat difficult to ascertain, but indications suggest a slow uptak